WHO technical advisory group to discuss Covaxin EUL on October 26

Published On 2021-10-18 07:36 GMT   |   Update On 2021-10-18 07:36 GMT

Hyderabad: The technical advisory group of the World Health Organisation (WHO) will meet on October 26 to consider emergency use listing for Bharat Biotech's COVID-19 vaccine Covaxin, tweeted Soumya Swaminathan, chief scientist of the global health body, on Sunday.

"The technical advisory group will meet on Oct 26th to consider EUL for #Covaxin. @WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use & to expand access to populations everywhere," she tweeted.

Advertisement

The Strategic Advisory Group of Experts on Immunization (SAGE) of the WHO which held a meeting on October 6 to make its recommendations on Covaxin on EUL, among other issues, had earlier said it will take a call on granting EUL status to Covaxin in a week time.

The EUL process being carried out by the WHO and the Technical Advisory Group of independent experts - is centered on determining if a manufactured product such as vaccine is quality-assured, safe and effective, WHO earlier said.

Advertisement

"The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is "October 2021" according to the update available on the WHO website," reports PTI.

Covaxin is one of the three vaccines that have received emergency use authorisation from India's drug regulator and is being used in the nationwide inoculation programme, along with Covishield and Sputnik V.

The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility.

The vaccine is developed using Whole-Virion Inactivated Vero Cell derived platform technology. Inactivated vaccines do not replicate and are therefore unlikely to revert and cause pathological effects. They contain dead virus, incapable of infecting people but still able to instruct the immune system to mount a defensive reaction against an infection.
Tags:    
Article Source : with agency inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News